Table 1.
Patients’ clinic features
| Case | Age (yr) | Sex | Before vortioxetine | 3-month follow-up | Prognosis | Additional treatment | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
||||||||||
| RLSSS | BDS | BAS | RLSSS | BDS | BAS | ||||||
| 1 | 61 | Female | 32 | 4 | 30 | 30 | 1 | 9 | Partial recovery | Gabapentin, pramipexole | |
| 2 | 52 | Female | 39 | 30 | 45 | 22 | 6 | 43 | Partial recovery | Gabapentin, pramipexole | |
| 3 | 45 | Male | 29 | 10 | 13 | 16 | 2 | 6 | Partial recovery | Gabapentin, pramipexole | |
| 4 | 36 | Female | 22 | 33 | 35 | 21 | 10 | 7 | No recovery | Gabapentin, pramipexole | |
| 5 | 47 | Female | 26 | 20 | 21 | - | - | - | Discontinued for side effect | Pramipexole | |
| 6 | 64 | Male | 39 | 25 | 27 | 24 | 1 | 1 | Full recovery | Pramipexole | |
| 7 | 45 | Female | 34 | 26 | 31 | 12 | 1 | 1 | Full recovery | No treatment | |
RLSS, Restless Leg Severity Score; BDS, Beck Depression Scale; BAS, Beck Anxiety Scale.